Previous close | 0.0385 |
Open | 0.0460 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0422 - 0.0470 |
52-week range | 0.0330 - 1.2500 |
Volume | |
Avg. volume | 40,470 |
Market cap | 1.243M |
Beta (5Y monthly) | -0.06 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics.
Nemaura Medical, Inc. (NMRD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.